Otezla Archives -

Amgen builds Otezla’s psoriasis label as rival BMS looms large

https://pharmaphorum.com/news/amgen-builds-otezlas-psoriasis-label-as-rival-bms-looms-large/

FDA sets Sept review date for BMS’ psoriasis drug deucravacitinib

https://pharmaphorum.com/news/fda-sets-sept-review-date-for-bms-psoriasis-drug-deucravacitinib/

Failed IBD trial dents confidence in BMS’ deucravacitinib

https://pharmaphorum.com/news/failed-ibd-trial-dents-confidence-in-bms-deucravacitinib/

Dermavant raises $200m to ease launch of Otezla rival tapinarof

https://pharmaphorum.com/news/dermavant-raises-200m-to-ease-launch-of-otezla-rival-tapinarof/

Amgen to test psoriasis pill Otezla in COVID-19

https://pharmaphorum.com/news/amgen-to-test-psoriasis-pill-otezla-in-covid-19/

Amgen stumps up $13.4bn to claim Otezla from Celgene

https://pharmaphorum.com/news/amgen-stumps-up-13-4bn-to-claim-otezla-from-celgene/

Celgene gets new approval for soon-to-be-shed Otezla

https://pharmaphorum.com/news/celgene-gets-new-approval-for-soon-to-be-shed-otezla/

BMS will shed Otezla to push Celgene takeover through

https://pharmaphorum.com/news/bms-will-shed-otezla-to-push-celgene-takeover-through/

Otezla gains NICE approval for psoriatic arthritis

https://pharmaphorum.com/news/otezla-gains-nice-approval-psoriatic-arthritis/

Search